Carmel Capital Partners LLC Sells 1,313 Shares of HCA Healthcare, Inc. $HCA

Carmel Capital Partners LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.2% in the third quarter, HoldingsChannel.com reports. The firm owned 4,343 shares of the company’s stock after selling 1,313 shares during the period. HCA Healthcare comprises 0.8% of Carmel Capital Partners LLC’s investment portfolio, making the stock its 29th largest position. Carmel Capital Partners LLC’s holdings in HCA Healthcare were worth $1,851,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth about $27,000. Clearstead Trust LLC lifted its position in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the period. Harbor Capital Advisors Inc. increased its stake in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $40,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

NYSE HCA opened at $466.10 on Friday. The stock has a market capitalization of $106.36 billion, a price-to-earnings ratio of 18.02, a PEG ratio of 1.28 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $520.00. The business’s fifty day moving average price is $480.40 and its 200-day moving average price is $432.89.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the prior year, the company earned $4.90 earnings per share. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

Analyst Upgrades and Downgrades

HCA has been the topic of several analyst reports. Sanford C. Bernstein reissued a “market perform” rating and issued a $503.00 target price on shares of HCA Healthcare in a report on Tuesday, January 6th. Mizuho raised their price objective on shares of HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research note on Thursday, December 18th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Leerink Partners boosted their price objective on shares of HCA Healthcare from $470.00 to $507.00 and gave the stock an “outperform” rating in a report on Thursday, January 15th. Finally, KeyCorp restated an “overweight” rating and issued a $500.00 price target on shares of HCA Healthcare in a research note on Thursday. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $488.75.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.